Who founded Vetmab Biosciences?

Vetmab Biosciences was founded by Denise Bevers in 2022.

How much funding has Vetmab Biosciences raised?

Vetmab Biosciences has disclosed $2.6M raised across 3 rounds.

Where is Vetmab Biosciences headquartered?

Vetmab Biosciences is headquartered in San Diego, US.

Vetmab Biosciences

San Diego, US · Founded 2022 · Delaware corporation

Find your way into Vetmab Biosciences

VETmAb BIO is a veterinary biotechnology company developing monoclonal antibody (mAb) therapeutics for dogs and cats. It targets veterinarians treating companion animals, and its founding team previously built and sold KindredBio.

Biotech Healthtech

Founders & leadership

Vetmab Biosciences was founded in 2022 by Denise Bevers.

Denise BeversCo-founder, President & CEO, Board Member

Richard ChinCo-founder, Chair of the Board

Hangjun ZhanCo-founder, Chair of the Scientific Advisory Committee, Board Member

Neeraj AgrawalNamed on SEC filing

Chrysa MineoNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$2.6M disclosed across 3 rounds · 2022–2023

▶$11.4MraisedSep 2026 · 30 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Denise BeversExecutive Officer, Director
Richard ChinExecutive Officer, Director
Hangjun ZhanDirector
Neeraj AgrawalDirector
Chrysa MineoDirector

Offering amount: $11.9M
Amount sold: $11.4M
First sale: Sep 2026
Incorporated: Corporation, Delaware, 2022
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$575KraisedDec 2023 · 5 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Denise BeversExecutive Officer, Director
Hangjun ZhanDirector
Richard ChinExecutive Officer, Director

Offering amount: $5M
Amount sold: $575K
First sale: Nov 2023
Incorporated: Corporation, Delaware, 2022
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$2MraisedAug 2022 · 28 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Hangjun ZhanDirector
Richard ChinExecutive Officer, Director
Denise Marie BeversExecutive Officer, Director

Offering amount: $2M
Amount sold: $2M
Minimum investment: $10K
First sale: Aug 2022
Incorporated: Corporation, Delaware, 2022
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$22raisedJul 2022 · 42 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Richard ChinDirector
Hangjun ZhanDirector
Denise Marie BeversExecutive Officer, Director

Offering amount: $22
Amount sold: $22
First sale: Jul 2022
Incorporated: Corporation, Delaware, 2022
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Vetmab Biosciences do?: VETmAb BIO is a veterinary biotechnology company developing monoclonal antibody (mAb) therapeutics for dogs and cats. It targets veterinarians treating companion animals, and its founding team previously built and sold KindredBio.
Who founded Vetmab Biosciences?: Vetmab Biosciences was founded by Denise Bevers in 2022.
How much funding has Vetmab Biosciences raised?: Vetmab Biosciences has disclosed $2.6M raised across 3 rounds.
Where is Vetmab Biosciences headquartered?: Vetmab Biosciences is headquartered in San Diego, US.